In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe

OBJECTIVES: Many carbapenem-resistant (CR) Gram-negative (GN) pathogens exhibit MDR, meaning few therapeutic options are available for CR-GN infections. Cefiderocol, a siderophore cephalosporin, has demonstrated in vitro efficacy against CR-GN bacteria. In the SIDERO-CR-2014–2016 surveillance study,...

Full description

Saved in:
Bibliographic Details
Published in:JAC Antimicrob Resist
Main Authors: Longshaw, Christopher, Manissero, Davide, Tsuji, Masakatsu, Echols, Roger, Yamano, Yoshinori
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8210120/
https://ncbi.nlm.nih.gov/pubmed/34223017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jacamr/dlaa060
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items